ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2,1,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
3,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
3,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3,3,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
3,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3,6,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
3,7,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3,8,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5,1,Application site macule,Application site reactions,Administration site reactions,Genrl,N
5,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
6,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
7,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
8,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
9,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
11,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
12,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
12,2,Application site scar,Application site reactions,Administration site reactions,Genrl,N
12,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
12,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
12,6,Skin test positive,Immunology skin tests NEC,Immunology and allergy investigations,Inv,N
13,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
13,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
14,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
14,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
15,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
16,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
17,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
18,1,Headache,Headaches NEC,Headaches,Nerv,N
18,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
18,3,Migraine,Migraine headaches,Headaches,Nerv,N
18,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
19,2,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
20,1,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
21,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
21,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
21,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
22,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
22,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
22,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
22,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
22,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
22,6,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
23,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
24,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
24,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
25,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
25,2,Application site laceration,Application site reactions,Administration site reactions,Genrl,N
25,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
